Glucagon-like peptide-1 analogues for type 2 diabetes

BMJ. 2011 Feb 16:342:d410. doi: 10.1136/bmj.d410.
No abstract available

MeSH terms

  • Diabetes Mellitus, Type 2 / drug therapy*
  • Exenatide
  • Female
  • Glucagon-Like Peptide 1 / adverse effects
  • Glucagon-Like Peptide 1 / analogs & derivatives*
  • Glucagon-Like Peptide 1 / therapeutic use
  • Humans
  • Hypoglycemic Agents / adverse effects
  • Hypoglycemic Agents / therapeutic use*
  • Liraglutide
  • Middle Aged
  • Peptides / adverse effects
  • Peptides / therapeutic use*
  • Venoms / adverse effects
  • Venoms / therapeutic use*

Substances

  • Hypoglycemic Agents
  • Peptides
  • Venoms
  • Liraglutide
  • Glucagon-Like Peptide 1
  • Exenatide